🇺🇸 FDA
Pipeline program

Berubicin hydrochloride

BER-PUM-01

Phase 2 small_molecule active

Quick answer

Berubicin hydrochloride for central nervous system (CNS) lymphomas is a Phase 2 program (small_molecule) at Rani Therapeutics Holdings with 1 ClinicalTrials.gov record(s).

Program details

Company
Rani Therapeutics Holdings
Indication
central nervous system (CNS) lymphomas
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials